Response to Vitrectomy in diabetic macular edema
نویسندگان
چکیده
منابع مشابه
Vitrectomy for persistent diffuse diabetic macular edema.
PURPOSE To evaluate the potential benefit of vitrectomy in eyes with persistent diffuse macular edema. DESIGN Prospective randomized comparative clinical trial. METHODS Eyes with diffuse diabetic macular edema for 6 to 18 months, an attached posterior hyaloid, and grid laser photocoagulation performed at least 4 months before were included. Patients were randomized either to a vitrectomy gr...
متن کاملVitrectomy for diabetic macular edema; where are we?
Diabetic retinopathy is the leading cause of visual impairment in the working age group mainly due to diabetic macular edema (DME). As the incidence of diabetes is increasing in human populations, the visual burden of DME is expected to expand. The standard treatment for DME has been macular laser photocoagulation for almost two decades but has shifted to intravitreal injection of anti-VEGF age...
متن کاملRemote Ischemic Preconditioning and Diabetic Macular Edema
Objective: Remote Ischemic Preconditioning (RIPC) as the transient ischemia and reperfusion of the arm is a promising method for protecting different tissue from future ischemia. These effects might be mediated through vascular and endothelial growth factor (VEGF) pathway. We investigated the influence of RIPC on diabetic macular edema (DME) as a chronic ischemic condition in patients who were ...
متن کاملVitrectomy Combined with Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Nontractional Diabetic Macular Edema
PURPOSE To evaluate the efficacy of vitrectomy combined with intravitreal injection of triamcinolone acetonide (IVTA) and macular laser photocoagulation for the treatment of nontractional diabetic macular edema (DME) refractory to anti-vascular endothelial growth factor (VEGF) therapy. METHODS Twenty-eight eyes from 28 subjects who were diagnosed with nontractional DME refractory to three or ...
متن کاملDiabetic Macular Edema
Introduction Over the last one decade the management of diabetic macular edema has undergone a paradigm change. This is attributed to the newer diagnostic tests and pharmacological agents. There are enough good randomized controlled trials to prove the efficacy of these drugs. However, in clinical practice, there are many situations where the application of the findings of these clinical trials...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Ophthalmology
سال: 2019
ISSN: 0008-4182
DOI: 10.1016/j.jcjo.2019.04.007